Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers

Disease Markers

Volumn 21, Issue 2, 2005, Pages 61-69

  Zvara, Ágnes ^a   Szekeres, György ^b   Janka, Zoltán ^b   Kelemen, János Z ^a   Cimmer, Csongor ^b   Sántha, Miklós ^c   Puskás, László G ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

Dopamine receptor D2 (DRD2); Inwardly rectifying potassium channel (Kir2.3); Lymphocyte; Microarray; Real time PCR; Schizophrenia

Indexed keywords

BIOCHEMICAL MARKER; DOPAMINE 2 RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; BIOLOGICAL MARKER; MESSENGER RNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; GENETIC SCREENING; HUMAN; LYMPHOCYTE; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; GENETICS; METABOLISM; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 21044441974     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/275318     Document Type: Article

References (38)

1. A. Abi-Dargham, J. Rodenhiser, D. Printz, Y. Zea-Ponce, R. Gil, L.S. Kegeles, R. Weiss, T.B. Cooper, J.J. Mann, R.L. Van Heertum, J.M. Gorman and M. Laruelle, Increased baseline occupancy of D2 receptors by dopamine in schizophrenia, Proc Natl Acad Sci USA 97 (2000), 8104-8109.
2. P.R. Albert, K.A. Neve, J.R. Bunzow and O. Civelli, Coupling of cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion, J Biochem 265 (1990), 2098-2104.
3. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, (4th ed.), Washington, DC: American Psychiatric Association, 1994.
4. J. Balázs and I. Bitter, [Study on construct validity of the M.I.N.I. PLUS interview], Psychiat Hung 15 (2000), 134-144.
5. P. Barbanti, G. Fabbrini, A. Ricci, G. Bruno, R. Cerbo, E. Bronzetti, F. Amenta and G. Luigi Lenzi, Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease, Mech Ageing Dev 120 (2000), 65-75.
6. N.H. Bishopric, H.J. Cohen and R.J. Lefkowitz, Beta adrenergic receptors in lymphocyte subpopulations, J Allergy Clin Immunol 65 (1980), 29-33.
7. B. Bondy, S. de Jonge, S. Pander, J. Primbs and M. Ackenheil, Identification of dopamine D4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction, J Neuroimmunol 71 (1996), 139-144.
8. N.A. Cohen, Q. Sha, E.N. Makhina, A.N. Lopatin, M.E. Linder, S.H. Snyder and C.G. Nichols, Inhibition of an inward rectifier potassium channel (Kir2.3) by G-protein betagamma subunits, J Biol Chem 271 (1996), 32301-32305.
9. + channels, Ann NY Acad Sci 868 (1999), 233-285.
10. N. Gorelova, J.K. Seamans and C.R. Yang, Mechanisms of dopamine activation of fast-spiking interneurons that exert inhibition in rat prefrontal cortex, J Neurophysiol 88 (2002), 3150-3166.
11. Y. Dong, D. Cooper, F. Nasif, X.T. Hu and F.J. White, Dopamine modulates inwardly rectifying potassium currents in medial prefrontal cortex pyramidal neurons, J Neurosci 24 (2004), 3077-3085.
12. Y. Hakak, J.R. Walker, C. Li, W.H. Wong, K.L. Davis, J.D. Buxbaum, V. Haroutunian and A.A. Fienberg, Genomewide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia, Proc Natl Acad Sci USA 98 (2001), 4746-4751.
13. T. Ilani, D. Ben-Shachar, R.D. Strous, M. Mazor, A. Sheinkman, M. Kotler and S. Fuchs, A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes, Proc Natl Acad Sci USA 98 (2001), 625-228.
14. S.R. Kay, A. Fiszbein and L.A. Opler, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophr Bull 13 (1987), 261-276.
15. Y.T. Kwak, M.S. Koo, C.H. Choi and I. Sunwoo, Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients, BMC Med Genet 2 (2001), 3.
16. N. Lavine, N. Ethier, J.N. Oak, L. Pei, F. Liu, P. Trieu, R.V. Rebois, M. Bouvier, T.E. Hebert and H.H. Van Toi, G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase, J Biol Chem 277 (2002), 46010-46019.
17. M. Levite, Y. Chowers, Y. Ganor, M. Besser, R. Hershkovits and L. Cahalon, Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function, Eur J Immunol 12 (2001), 3504-3512.
18. D.A. Lewis and J.A. Lieberman, Catching up on schizophrenia: natural history and neurobiology, Neuron 28 (2000), 325-334.
19. E.R. Marcotte, L.K. Srivastava and R. Quirion, cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer's disease, Pharmacol Ther 100 (2003), 63-74.
20. F. McKenna, P.J. McLaughlin, B.J. Lewis, G.C. Sibbring, J.A. Cummerson and D. Bowen-Jones, Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study, J Neuroimmunol 132 (2002), 34-40.
21. F.A. Middleton, K. Mirnics, J.N. Pierri, D.A. Lewis and P. Levitt, Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia, J Neurosci 22 (2002), 2718-2729.
22. K. Mirnics, F.A. Middleton, D.A. Lewis and P. Levitt, Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse, Trends Neurosci 24 (2001), 479-486.
23. K. Mirnics, F.A. Middleton, G.D. Stanwood, D.A. Lewis and P. Levitt, Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia, Mol Psychiatry 6 (2001), 293-301.
24. K. Mirnics, F.A. Middleton, A. Marquez, D.A. Lewis and P. Levitt, Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex, Neuron 28 (2000), 53-67.
25. H. Myeong, D. Jeoung, H. Kim, J.H. Ha, Y. Lee, K.H. Kim, C. Park and B.K. Kaang, Genomic analysis and functional expression of canine dopamine D2 receptor, Gene 257 (2000), 99-107.
26. A. Onody, A. Zvara, L. Hackler, Jr., L. Vigh, P. Ferdinandy and L.G. Puskas, Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study, FEBS Lett 536 (2003), 35-40.
27. F. Perier, C.M. Radeke and C.A. Vandenberg, Primary structure and characterization of a small-conductance inwardly rectifying potassium channel from human hippocampus, Proc Natl Acad Sci USA 91 (1994), 6240-6244.
28. O. Perl, T. Ilani, R.D. Strous, R. Lapidus and S. Fuchs, The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes, FASEB J 17 (2003), 1948-1950.
29. M.W. Pfaffl, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res 29 (2001), e45.
30. L.G. Puskas, L. Hackler, Jr., G. Kovacs, Z. Kupihar, A. Zvara, T. Micsik and P. van Hummelen, Recovery of cyanine-dye nucleotide triphosphates, Anal Biochem 305 (2002), 279-281.
31. A. Ricci, E. Bronzetti, L. Felici, S. Greco and F. Amenta, Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H] 7-OH-DPAT: a combined radioligand binding assay and immunochemical study, J Neuroimmunol 92 (1998), 191-195.
32. A. Ricci, E. Bronzetti, L. Felici, S.K. Tayebati and F. Amenta, Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study, Neurosci Lett 229 (1997), 130-134.
33. A. Ricci, F. Veglio and F. Amenta, Radioligand binding characterization of putative dopamine D3 receptor in human peripheral blood lymphocytes with [3H] 7-OH-DPAT, J Neuroimmunol 58 (1995), 139-144.
34. D.A. Roberts, D. Balderson, S.M. Pickering-Brown, J.F. Deakin and F. Owen, The abundance of mRNA for dopamine D2 receptor isoforms in brain tissue from controls and schizophrenics, Brain Res Mol Brain Res 25 (1994), 173-175.
35. P. Seeman, Dopamine receptors and the dopamine hypothesis of schizophrenia, Synapse 1 (1987), 133-152.
36. T. Tallerico, G. Novak, I.S. Liu, C. Ulpian and P. Seeman, Schizophrenia: elevated mRNA for dopamine D2 (Longer) receptors in frontal cortex, Brain Res Mol Brain Res 87 (2001), 160-165.
37. + channel in acutely dissociated rat substantia nigra neurons, Neuropharmacology 39 (2000), 191-201.
38. M.P. Vawter, E. Ferran, B. Galke, K. Cooper, W.E. Bunney and W. Byerley, Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree, Schizophr Res 67 (2004), 41-52.